Risk of Gonococcal Infection During Vaginal Exposure is Associated with high Vaginal pH and Active Menstruation

Por McLaughlin, Stephanie E., Ghanem, Khalil G., Zenilman, Jonathan M., Griffiss, J. McLeod
Publicado no Sex Transm Dis (2019)

Neisseria gonorrhoeae Coordinately Uses Pili and Opa To Activate HEC-1-B Cell Microvilli, Which Causes Engulfment of the Gonococci

Por Griffiss, J. McLeod, Lammel, Claudia J., Wang, Jun, Dekker, Nusi P., Brooks, G. F.
Publicado em 1999

Biochemical Analysis of Lpt3, a Protein Responsible for Phosphoethanolamine Addition to Lipooligosaccharide of Pathogenic Neisseria

Por O'Connor, Ellen T., Piekarowicz, Andrzej, Swanson, Karen V., Griffiss, J. McLeod, Stein, Daniel C.
Publicado em 2006

Neisseria gonorrhoeae-induced transactivation of EGFR enhances gonococcal invasion

Por Swanson, Karen V., Griffiss, J. McLeod, Edwards, Vonetta L., Stein, Daniel C., Song, Wenxia
Publicado no Cell Microbiol (2011)

Antibody-dependent Mononuclear Cell-mediated Antimeningococcal Activity: COMPARISON OF THE EFFECTS OF CONVALESCENT AND POSTIMMUNIZATION IMMUNOGLOBULINS G, M, AND A

Por Lowell, George H., Smith, Lynette F., Griffiss, J. McLeod, Brandt, Brenda L., MacDermott, Richard P.
Publicado em 1980

Functional Activities and Immunoglobulin Variable Regions of Human and Murine Monoclonal Antibodies Specific for the P1.7 PorA Protein Loop of Neisseria meningitidis

Por Wang, Jianfu, Jarvis, Gary A., Achtman, Mark, Rosenqvist, Einar, Michaelsen, Terje E., Aase, Audun, Griffiss, J. McLeod
Publicado em 2000

Urethral Exudates of Men with Neisseria gonorrhoeae Infections Select a Restricted Lipooligosaccharide Phenotype During Transmission

Por McLaughlin, Stephanie E., Cheng, Hui, Ghanem, Khalil G., Yang, Zhijie, Melendez, Johan, Zenilman, Jonathan, Griffiss, J. McLeod
Publicado em 2012

Human Lipooligosaccharide IGG That Prevents Endemic Meningococcal Disease Recognizes an Internal Lacto-N-neotetraose Structure

Por Cheng, Hui, Yang, Zhijie, Estabrook, Michele M., John, Constance M., Jarvis, Gary A., McLaughlin, Stephanie, Griffiss, J. McLeod
Publicado em 2011

Structural Characterization of an Oligosaccharide Made by Neisseria sicca

Por O'Connor, Ellen T., Zhou, Hui, Bullock, Kevin, Swanson, Karen V., Griffiss, J. McLeod, Reinhold, Vernon N., Miller, Clinton J., Stein, Daniel C.
Publicado em 2009

Phase 1 Clinical Trials of DAS181, an Inhaled Sialidase, in Healthy Adults

Por Zenilman, Jonathan M., Fuchs, Edward J., Hendrix, Craig W., Radebaugh, Christine, Jurao, Robert, Nayak, Seema U., Hamilton, Robert G., Griffiss, J. McLeod
Publicado no Antiviral Res (2015)

Impact of Rifabutin or Rifampin on Bedaquiline Safety, Tolerability, and Pharmacokinetics Assessed in a Randomized Clinical Trial with Healthy Adult Volunteers

Por Healan, Amanda M., Griffiss, J. McLeod, Proskin, Howard M., O'Riordan, Mary Ann, Gray, Wesley A., Salata, Robert A., Blumer, Jeffrey L.
Publicado no Antimicrob Agents Chemother (2017)

Mycobactericidal activity of bedaquiline plus rifabutin or rifampin in ex vivo whole blood cultures of healthy volunteers: A randomized controlled trial

Por Wallis, Robert S., Good, Caryn E., O’Riordan, Mary A., Blumer, Jeffrey L., Jacobs, Michael R., Griffiss, J. McLeod, Healan, Amanda, Salata, Robert A.
Publicado no PLoS One (2018)

Lack of Lipid A Pyrophosphorylation and Functional lptA Reduces Inflammation by Neisseria Commensals

Por John, Constance M., Liu, Mingfeng, Phillips, Nancy J., Yang, Zhijie, Funk, Courtney R., Zimmerman, Lindsey I., Griffiss, J. McLeod, Stein, Daniel C., Jarvis, Gary A.
Publicado em 2012

A two-part phase I study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonization of Staphylococcus aureus: A previously inv...

Por Yendewa, George A., Griffiss, J. McLeod, Jacobs, Michael R., Winkle, Peter, Gray, Wesley A., Proskin, Howard M., O’Riordan, Mary Ann, Fulton, Scott A., Salata, Robert A.
Publicado no J Glob Antimicrob Resist (2019)

A Response Adaptive Randomization Platform Trial for Efficient Evaluation of Ebola Virus Treatments: A Model for Pandemic Response

Por Berry, Scott M., Petzold, Elizabeth A., Dull, Peter, Thielman, Nathan M., Cunningham, Coleen K., Corey, G. Ralph, McClain, Micah T., Hoover, David L., Russell, James, Griffiss, J. McLeod, Woods, Christopher W.
Publicado no Clin Trials (2016)

Safety, Tolerability, Systemic Exposure, and Metabolism of CRS3123, a Methionyl-tRNA Synthetase Inhibitor Developed for Treatment of Clostridium difficile, in a Phase 1 Study

Por Nayak, Seema U., Griffiss, J. McLeod, Blumer, Jeffrey, O'Riordan, Mary Ann, Gray, Wesley, McKenzie, Robin, Jurao, Robert A., An, Amanda T., Le, Melissa, Bell, Stacie J., Ochsner, Urs A., Jarvis, Thale C., Janjic, Nebojsa, Zenilman, Jonathan M.
Publicado no Antimicrob Agents Chemother (2017)